Last update:

Oncology news

New, more effective delivery method for eye cancer treatment is derived from pig semen

Getting past the barrier surrounding the eye is a difficult but necessary part of treating retinoblastoma (RB)—a form of eye cancer that is more common in children. Once the barrier is penetrated, RB responds well to treatment. ...

Cysteine pathways help T cells choose between multiplying and attacking tumors

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Bloomberg School of Public Health has discovered how the immune system's CD8+ T cells ...

Vaping is likely to cause cancer, say new findings

Nicotine-based vapes (e-cigarettes) are likely to cause cancers of the lung and oral cavity, according to a new study led by UNSW Sydney and published today in Carcinogenesis. The study is titled "The carcinogenicity of e-cigarettes: ...

FDA warns biotech firm over cancer drug claims

The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.

AI model can predict chemotherapy benefit in breast cancer

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from ...

A promising new drug for an invasive type of breast cancer

EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening the door to future clinical ...

Paradigm shift in immune checkpoint biology

A research team led by Professor Ki-Young Lee at the College of Medicine, Sungkyunkwan University, has uncovered a previously unrecognized tumor-intrinsic role of the immune checkpoint molecule PD-L1, providing new mechanistic ...

Vitamin B7 reveals a new metabolic weak spot in some cancers

A research group at the University of Lausanne (Unil) has identified a new mechanism that exposes the vulnerability of tumor cells when they are deprived of vitamin B7. The ability of cells to adapt to fluctuations in nutrient ...